Leverage a range of research and development solutions to improve the productivity of oncology drug development

Learn more about humanized mouse models for the preclinical evaluation of novel immunotherapies

Identify PDX cohorts based on molecular characteristics, patient treatment, standard-of-care testing outcomes, clinical features and more

Enrollment ends August 31